4.01%| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 4.01 | 49.38 | 1.55 | 5.03 | 5.95 |
| Classification | 4.42 | 53.71 | -3.71 | 1.98 | 1.74 |
| Index (S&P 500) | 4.50 | 51.20 | -4.00 | 1.60 | -0.50 |
| % Rank in Class (1-best,100=worst) | 57 | 66 | 5 | 7 | 13 |
| Investment Objective: | Mid-Cap |
|---|---|
| Net Assets ($Mil) | 1,574.30 |
| Inception Date: | 6/9/87 |
| Manager Name, Tenure | Sloan/Assiello/Nelson, 1998 / 2007 / 2007 |
| Expense Ratio: | 1.24% |
|
Sales Charge:
Load Type:
|
Front-End Load 5.50% 0.00% |
| Company Name | Symbol | % Net Assets |
|---|---|---|
| Aim Liquid Assets Portfolio;institutional | NA | 8.23 |
| Aim Premier Portfolio;institutional | NA | 8.23 |
| Symantec Corp | SYMC | 2.34 |
| Peoples United Financial Inc | PBCT | 2.00 |
| Safeway Inc | SWY | 1.91 |
| Boston Scientific Corp | BSX | 1.74 |
| Pharmaceutical Product Development | PPDI | 1.66 |
| Henkel Ag & Co. Kgaa | HENOF | 1.65 |
| Zimmer Hldgs | ZMH | 1.63 |
| Varian Medical Systems Inc | VAR | 1.57 |
| % of Total Holdings | 30.96 | |
| 2/20/2009 | Four little-known bank stocks that rate a buy amid the carnage (MarketWatch.com) |
| 9/24/2008 | Strategies From a Top Mid-Cap Fund Manager (SM) |